RESEARCH ON VARIOUS PLASMA NT-PROBNP AND CHARACTERISTICS ARRHYTHMIAS OF THE HEART FAILURE IN STABLE ISCHEMIC HEART DISEASE

Đoàn Thịnh Trường, Nguyễn Oanh Oanh, Nguyễn Quang Toàn

Main Article Content

Abstract

Objectives: To various plasma NT-proBNP and characteristics arrhythmia of the heart failure in stable ischemic heart disease. Subjects and methods: A cross-sectional descriptive study on 136 chronic heart failure were diagnosed as stable ischemic heart disease at Military Hospital 103 and Hanoi Heart Hospital from October 2016 to January 2021. Participants were eligible for inclusion and exclusion criteria. NT-proBNP was taken at the admission and after treatment. Medical statistical algorithm was used to determine the correlation between symptoms of heart failure, ventricular arrhythmia and plasma NT-proBNP. Results: The group  over 75 years old had the highest mean NT-proBNP level 3468,975 ± 7876,498 pg/ml. The group under 50 years old had the lowest value 519,139±160,953pg/ml. The difference was significant with p = 0.017. NT-proBNP all had changes, the older the group, the higher the value. NT-proBNP concentrations in the group with decreased left ventricular ejection function were found to be higher than those in the group with normal or slightly decreased left ventricular systolic function. The number of ventricular ectopic units also had a remarkable change before and after treatment, the number of ventricular extrasystole significantly decreased after the treatment, the difference was significant p <0.001. Conclusion: NT-proBNP are related to age and severity according to NYHA, and inverse association between NT-proBNP and left ventricular ejection function. Cardiac arrhythmias, especially premature ventricular complexes are most common in heart failure patients with chronic ischemic heart disease.

Article Details

References

1. Knuuti J., Wijins W., Saraste A., et al. (2019). 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC). European Heart Journal., 00: 1-71
2. Phạm Mạnh Hùng và cộng sự. (2019). Lâm sàng tim mạch học. Nhà xuất bản Y học.
3. Sadanandan S., Cannon CP., Chekuri K., et al. (2004). Association of elevated B-tupe natriuretic peptide levels with angiographic finding among patients with unstable angina and non-ST segmant eevation myocardial infarction. J Am Coll Cardiol., 44(3): 564-568.
4. Viên Hoàng Long và cộng sự. (2013). Nghiên cứu một số đặc điểm lâm sàng và cận lâm sàng trên bệnh nhân BMV mang YTNC tồn dư tại Khoa Khám - BV Bạch Mai. Tạp chí Tim Mạch Học, số 63:28-32
5. Hendricks S., Dykun I., Balcer B., et al. (2020). Higher BNP/NT-proBNP levels stratify prognosis in patients with coronary artery disease but without heart failure. European Heart Journal., 41 (Supp 2): ehaa946.1335.
6. Sokhanvar S., Shekhi M., Mazlomzadeh S., et al. (2011). The Relationship between Serum NT- Pro-BNP Levels and Prognosis in Patients with Systolic Heart Failure. Cardiovasc Thorac Res., 3(2): 57-61.
7. Zhaohua Geng., Lan Huang., Mingbao Song., et al. (2017). N-terminal pro-brain natriuretic peptide and cardiovascular or all-cause mortality in the general population: A meta-analysis. Sci Rep., 30 (7): 41504.
8. Januzzi J.L., Camargo C.A., Anwaruddin S., et al. (2005). The N-terminal pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol., 95(8): 948-954.
9. Tạ Mạnh Cường và cộng sự. (2010). Nghiên cứu nồng độ Pro-B type Natriueretic peptide (Pro - BNP) của bệnh nhân suy tim mạn tính. Tạp chí Y học Việt Nam, số 2: 36-42.